ArticleInternational journal of clinical oncology2025

Lung immune prognostic index as a biomarker for predicting the benefit of immune checkpoint inhibitor plus chemotherapy in older patients with non-small cell lung cancer: a secondary analysis of the NEJ057 study.

Takehiro Tozuka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.